- Home
- / Radiopharm Theranostics
Radiopharm Theranostics
Stock Price
$0
2024-10-04
Revenue
$3.6 M
FY, 2025
Radiopharm Theranostics Summary
Company Summary
- Overview
- Radiopharm Theranostics is a biotech company. It offers radiopharmaceutical and nuclear medicine products
- Type
- Public
- Status
- Active
- Founded
- 2014
- Cybersecurity rating
Table of Contents
Radiopharm Theranostics Financials
Summary Financials
- Revenue (H1, 2026)
- $1.4M
- Gross profit (H1, 2026)
- $4.7M
- Net income (H1, 2026)
- ($28.2M)
- Cash (H1, 2026)
- $34.5M
- EBIT (H1, 2026)
- ($27.9M)
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026